Sander van Deventer

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

Geert D’Haens, Filip Baert, Gert Van Assche et al. · The Lancet · 2008 · 1.2K citations

Medicine, Clinical Sciences, Immunology +12

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations

Jochen Hampe, Andrew Cuthbert, Peter J.P. Croucher et al. · The Lancet · 2001 · 1.1K citations

Medicine, Genetics, Molecular Genetics +16

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn, Jean‐Frédéric Colombel, Roberts Enns et al. · New England Journal of Medicine · 2005 · 926 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

Geert D’Haens, Sander van Deventer, Ruud van Hogezand et al. · Gastroenterology · 1999 · 756 citations · Full text

Veterinary Medicine, Immunology, Internal Medicine +14

Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease

Daan W. Hommes, Bernt van den Blink, Terry F. Plasse et al. · Gastroenterology · 2002 · 382 citations · Full text

Life Sciences, Immunology, Pharmacology +14